Bovine Lactate Dehydrogenase (Bos taurus)
Bovine Lactate Dehydrogenase (Bos taurus) is a tetrameric enzyme that catalyzes the interconversion of pyruvate and lactate using NAD+/NADH as a cofactor, playing a central role in anaerobic glycolysis. It has no established therapeutic applications in humans and is used primarily as a biochemical reagent in laboratory assays.

Origin & History
Bovine Lactate Dehydrogenase (LDH) is an enzyme derived from Bos taurus (cattle), primarily extracted from tissues such as heart or skeletal muscle. It belongs to the NAD+-dependent oxidoreductases class, catalyzing the reversible conversion of L-lactate and pyruvate. The enzyme is typically purified from bovine tissues for biochemical research purposes, with no commercial extraction methods for supplement use documented.
Historical & Cultural Context
No historical or traditional medicinal use has been identified in any system including Ayurveda or Traditional Chinese Medicine. Sources describe bovine LDH exclusively as an endogenous enzyme or laboratory-purified protein without any ethnomedical context.
Health Benefits
• No clinically proven health benefits - No human clinical trials identified in the research • Potential allergen concern - Recognized as Bos d LD allergen from beef consumption • Biochemical research tool only - Used exclusively for laboratory studies, not therapeutic applications • No evidence of supplemental use - Sources describe only endogenous role and enzyme characterization • No therapeutic data available - Absence of RCTs, meta-analyses, or clinical studies for human use
How It Works
Bovine Lactate Dehydrogenase catalyzes the reversible oxidation of L-lactate to pyruvate, transferring a hydride ion to NAD+ to produce NADH in the process. The enzyme operates as a homotetramer or heterotetramer of M (muscle) and H (heart) subunits, with substrate binding occurring at the active site through conserved residues including His193 and Arg171, which stabilize the oxamate transition state. When present in human biological systems via dietary exposure, it does not meaningfully integrate into human metabolic pathways due to proteolytic digestion in the gastrointestinal tract.
Scientific Research
No human clinical trials, RCTs, or meta-analyses were identified for bovine LDH as a supplement. The research focuses solely on biochemical characterization, enzyme structure, and its endogenous role in metabolism. No PMIDs for therapeutic studies were found as this enzyme has not been studied for human supplementation.
Clinical Summary
No human clinical trials have been conducted to evaluate Bovine Lactate Dehydrogenase as a therapeutic or supplemental agent. Its relevance in human health research is largely confined to its identification as the Bos d LD allergen, documented in case reports and IgE-mediated allergy studies related to beef and dairy sensitization. In vitro and animal studies use the enzyme as a cytotoxicity marker—LDH release assays quantify cell membrane damage—but these do not translate to supplemental use in humans. The overall evidence base is biochemical and immunological in nature, not clinical or nutritional.
Nutritional Profile
Bovine Lactate Dehydrogenase (LDH) is a tetrameric protein enzyme (~135 kDa molecular weight) composed of four polypeptide subunits (M and H type combinations), each subunit approximately 33-36 kDa. As a pure protein enzyme, its macronutrient contribution is entirely proteinaceous when consumed incidentally through beef or dairy. Amino acid composition includes significant proportions of glutamic acid, aspartic acid, lysine, and leucine consistent with conserved mammalian LDH sequences. Contains no lipids, carbohydrates, or fiber intrinsically. Micronutrient profile: requires NAD+/NADH as cofactor for catalytic activity; binds zinc ions at structural sites in some isoforms. Catalytic mechanism involves the coenzyme nicotinamide adenine dinucleotide (NAD+) at a concentration of approximately 1 mol per subunit binding site. Bioavailability note: when ingested orally, LDH is denatured and proteolytically degraded in the gastrointestinal tract into constituent amino acids and peptides — no intact enzymatic activity is absorbed systemically. Caloric contribution is negligible given trace quantities present in food matrices. As an allergen (Bos d LD), intact or partially digested epitopes may trigger IgE-mediated responses in sensitized individuals before full proteolytic breakdown occurs. No vitamins, minerals, or bioactive compounds beyond its protein structure are associated with this enzyme.
Preparation & Dosage
No clinically studied dosage ranges exist for bovine LDH as it is not used as a human supplement. The enzyme is described only as a research tool with no standardization, extract, or powder forms for clinical dosing reported. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Not applicable - no synergistic ingredients identified due to lack of supplement use
Safety & Interactions
Bovine Lactate Dehydrogenase is recognized as an allergen (Bos d LD) and may trigger IgE-mediated allergic reactions in individuals sensitized to beef or dairy proteins, including urticaria, angioedema, or anaphylaxis in severe cases. No formal drug interaction data exists because the enzyme is not used as a supplement or pharmaceutical. Individuals with known beef or dairy allergies should avoid any product containing bovine-derived enzymes. Pregnancy safety has not been studied, and no regulatory body has established a safe supplemental dose.